Valproic acid and plasma levels of phenytoin
J. Bruni, B. J. Wilder, L. James Willmore, Benjamin H. Barbour
Abstract
J. Bruni, B. J. Wilder, L. James Willmore, Benjamin H. Barbour
Abstract
Eight patients were treated concurrently with a constant dose of phenytoin and valproic acid for 1 year. During initial therapy with valproic acid, total plasma phenytoin levels decreased. The interaction was transient and was not observed at the end of 1 year. Total plasma phenytoin levels returned to pre-valproic-acid levels in seven patients.
OpenAlex reports 27 citations for this work. Citation counts describe recorded attention and do not establish research quality.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Eight patients were treated concurrently with a constant dose of phenytoin and valproic acid for 1 year. During initial therapy with valproic acid, total plasma phenytoin levels decreased. The interaction was transient and was not observed at the end of 1 year. Total plasma phenytoin levels returned to pre-valproic-acid levels in seven patients.
Key concepts: Phenytoin, Valproic Acid, Anticonvulsant, Plasma concentration, Plasma levels, Pharmacology, Epilepsy, Medicine